GermanCol,
Exactly! What the bears don’t want to talk about is that Linda Powers has been in business longer than all those who crashed and burned or got bought out for peanuts by big pharma since 1996.
Linda has brought this company out of the ash heap multiple times, kept the trial going even when funding opportunities dried up by shutting it down with new enrollment for a while and now has brought this trial to it’s soon to be announced successful conclusion all while enlisting help developing a practical method for manufacturing at a worldwide commercial scale for SOC in GBM, rGBM, lower grade gliomas and astrocytomas. She also solidified patent protection for all processes involved in differentiating DCs to maximum effect and use of certain combos by schooling folks in the patent office into allowing what was once disallowed. She did all this while Dr. Linda Liau helped school her peer group and regulators about the need for historical controls, a new definition for GBM and new measures to take treatment related pseudoprogression into account while also working to develop additional biomarkers to help identify best treatment regimen for each patient. While they were doing this Dr. Bosch was working on perfecting DCVax-Direct which is ready to be as impactful as a 12.0 earthquake when allowed loose off the chains. Going to be lots of bear rugs on display here soon. Best wishes.
News 
Market Data 
Discover 
